Inventor

NZEREM JERRY

US14 patents

⚠️ This page may combine multiple inventors who share the name “NZEREM JERRY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

THERAVANCE BIOPHARMA R&D IP LLC

12 patents

US10493077B2Dec 3, 2019

Fused imidazo-piperidine JAK inhibitor compound

THERAVANCE BIOPHARMA R&D IP LLC14 citations94

US10251874B2Apr 9, 2019

Crystalline forms of a JAK inhibitor compound

THERAVANCE BIOPHARMA R&D IP LLC23 citations93

US10308646B2Jun 4, 2019

Pyrimidine compound as JAK kinase inhibitor

THERAVANCE BIOPHARMA R&D IP LLC11 citations92

US10538513B2Jan 21, 2020

Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors

THERAVANCE BIOPHARMA R&D IP LLC4 citations83

US10392368B2Aug 27, 2019

Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors

THERAVANCE BIOPHARMA R&D IP LLC5 citations80

US11160810B2Nov 2, 2021

Fused imidazo-piperidine JAK inhibitor compound

THERAVANCE BIOPHARMA R&D IP LLC2 citations73

US10968205B2Apr 6, 2021

Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors

THERAVANCE BIOPHARMA R&D IP LLC1 citations72

US12172994B2Dec 24, 2024

Pyrimidine compound as JAK kinase inhibitor

THERAVANCE BIOPHARMA R&D IP LLC0 citations62

US11814377B2Nov 14, 2023

Pyrimidine compound as JAK kinase inhibitor

THERAVANCE BIOPHARMA R&D IP LLC0 citations62

US9868698B2Jan 16, 2018

(2S,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydroxymethyl-2-methylpentanoic acid

THERAVANCE BIOPHARMA R&D IP LLC0 citations52

US9670143B2Jun 6, 2017

(2S,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydroxmethyl-2-methylpentanoic acid

THERAVANCE BIOPHARMA R&D IP LLC0 citations52

US9433598B2Sep 6, 2016

(2S,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydroxymethyl-2-methylpentanoic acid

THERAVANCE BIOPHARMA R&D IP LLC0 citations52

THALLADI VENKAT R

2 patents

US9271965B2Mar 1, 2016

Crystalline forms of (R)-3-[N-(3'-chlorobiphenyl-4-ylmethyl)-N'-(3-hydroxyisoxazole-5-carbonyl)hydrazino]-2-hydroxyproprionic acid isopropyl ester

THALLADI VENKAT R0 citations36

US8883135B2Nov 11, 2014

Crystalline form of a pyridyl-piperazinyl hepatitis C virus inhibitor

THALLADI VENKAT R0 citations36